It has exceeded the national low-cost drug pricing standard, 4 enterprises have suspended drug online, Chengdu Beite, Southwest Pharmaceutical, China Otsuka Pharmaceutical

Recently, Hainan Provincial Pharmaceutical centralized procurement service platform issued a notice that lidocaine hydrochloride injection of four enterprises, namely Southwest Pharmaceutical Co., Ltd., Chengdu Beite Pharmaceutical Co., Ltd., China Otsuka Pharmaceutical Co., Ltd and Zhengzhou Zhuofeng Pharmaceutical Co., Ltd., was suspended because the online price exceeded the national low price drug pricing standard Lidocaine hydrochloride injection is a local anesthetic and antiarrhythmic drug It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopic examination or celiac operation) and nerve conduction block It can be used in ventricular premature beat and ventricular tachycardia after acute myocardial infarction, digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheters It is usually ineffective for supraventricular arrhythmia Lidocaine is the first kind of aminoamide local anesthetics It was first synthesized by Nils L ö fgren, a Swedish chemist, in 1943 It was named "Xylocaine" and first marketed in 1949 As a general drug, it is included in the list of essential drugs of the World Health Organization Various medical institutions and pharmaceutical enterprises: our center has recently removed some pharmaceuticals from the centralized drug purchase platform in Hainan, and now the information on the types of drugs removed from the network is published (see the annex for details) Notice is hereby given Attachment of Hainan public resources trading service center on March 19, 2019: summary of information changes of winning (online) drugs.